Please login to the form below

Not currently logged in
Email:
Password:

Calchan names Zahid Ali as chief scientific officer

Ali joins from Pfizer where he was a senior director

edit-calchan-zahid-aliUK-based biotech company Clachan has appointed Zahid Ali as chief scientific officer.

Calchan works with a focus on research and development of novel molecules targeting pain and imflammation, complementing Ali's two decades of industry experience and extensive knowledge of the area.

Commenting on his appointment, Ali said: “I am very excited to be joining Calchan, which has a management team of enviable experience and a very successful track record in the sector. 

“I believe the company's products have significant potential and I am looking forward to working with the team to secure Calchan's position as a leader in this field.”

Ali joins from Pfizer, where he held the position of senior director of clinical research and was responsible for a number of early clinical development programmes focused on pain research.

He began his career at Merck Sharp and Dohme Research Laboratories UK before increasing his seniority at companies including GSK, where he worked as director of discovery medicine.

Brenda Reynolds, CEO at Calchan, added: “Zahid Ali's appointment is an important one as we continue to assemble a strong team to develop our assets at Calchan. I am delighted that Zahid has chosen to join us as his considerable experience and background, notably as a Clinical Director at Pfizer, will be invaluable.”

15th May 2015

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....